Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) Subunit | ACS Medicinal Chemistry Letters
LogD Contributions of Substituents Commonly Used in Medicinal Chemistry | ACS Medicinal Chemistry Letters
Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-γ Inhibitors | Journal of Medicinal Chemistry
Discovery of 5-Nitro-6-thiocyanatopyrimidines as Inhibitors of Cryptococcus neoformans and Cryptococcus gattii | ACS Medicinal Chemistry Letters
MOARF, an Integrated Workflow for Multiobjective Optimization: Implementation, Synthesis, and Biological Evaluation | Journal of Chemical Information and Modeling
In Search of the Optimal Macrocyclization Site for Neurotensin | ACS Medicinal Chemistry Letters
Design of Selective Benzoxazepin PI3Kδ Inhibitors Through Control of Dihedral Angles | ACS Medicinal Chemistry Letters
Rational Alteration of Pharmacokinetics of Chiral Fluorinated and Deuterated Derivatives of Emixustat for Retinal Therapy | Journal of Medicinal Chemistry
Discovery of APD371: Identification of a Highly Potent and Selective CB2 Agonist for the Treatment of Chronic Pain | ACS Medicinal Chemistry Letters
Structure–Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) Antagonists | Journal of Medicinal Chemistry
The “Cyclopropyl Fragment” is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules | Journal of Medicinal Chemistry
Synthesis of Thymoquinone–Artemisinin Hybrids: New Potent Antileukemia, Antiviral, and Antimalarial Agents | ACS Medicinal Chemistry Letters
Synthesis and Cell-Based Activity of a Potent and Selective Protein Tyrosine Phosphatase 1B Inhibitor Prodrug | Journal of Medicinal Chemistry
Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ Inhibitors | ACS Medicinal Chemistry Letters
Multifunctional Carrier Based on Halloysite/Laponite Hybrid Hydrogel for Kartogenin Delivery | ACS Medicinal Chemistry Letters
Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor | ACS Medicinal Chemistry Letters
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity | Journal of Medicinal Chemistry
Forging Odd-Membered Rings: Palladium-Catalyzed Asymmetric Cycloadditions of Trimethylenemethane | Accounts of Chemical Research
Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy - ScienceDirect
Discovery of Novel BRD4 Ligand Scaffolds by Automated Navigation of the Fragment Chemical Space | Journal of Medicinal Chemistry
ACS Medicinal Chemistry Letters | Vol 11, No 11
Journal of Natural Products Special Issue Honors Drs. Rachel Mata and Barbara N. Timmermann - ACS Axial | ACS Publications
Small Molecules Promote Selective Denaturation and Degradation of Tubulin Heterodimers through a Low-Barrier Hydrogen Bond | Journal of Medicinal Chemistry
